Viatris (VTRS): 2 Catalysts Propelling THIS Stock of the Week

In recommending Viatris (VTRS), I am playing on 2 themes in my 2026 investment plan. 

First, is that lower rates favors income stocks. Thus, it is good to know that VTRS recently sprang up as 1 of the top 7 picks from the Income portfolio inside the Zen Strategies service.

Second, is that many large caps as a whole are pretty fully valued after 3 years of hefty bull market gains. Especially Mega Caps, Big Tech and other over-crowded AI stocks. Thus, I expect the recent sector rotation out of those names to continue. 

This means that large cap investors should be more drawn to something like Viatris…that being a healthy growth company in the pharma space trading at a much more attractive valuation. 

Add the two together and you understand the immediate appeal in Viatris, a leader in generic drugs (formerly known as Mylan).

As an extra catalyst I note a clear turnaround in their earnings prospects after several years of weakness. This shows up loud in clear in their last 3 earnings reports having earnings prospects and the share price on the rise.

Yet even now the company is only trading for a PE of 6.3X earnings estimates for the year ahead. That says to me there is a lot more upside potential in VTRS as the turnaround continues to unfold.

As with all my picks it sparkles in the light of the Zen Ratings in the top 4% for all stocks analyzed. That is much harder to do for an established large cap pharma company. Yet still they dazzle with the following component score breakdown:

Top 22% Value

Top 21% Sentiment

Top 16% Growth

Top 12% Momentum

Top 8% Safety

That is a well rounded fundamental profile that points to more good times ahead for these shares. 

No...I don’t expect this one will get your heart racing like some of my other Stock of the Week selections. But in constructing a diversified portfolio of stocks it is wise to have solid anchors like VTRS in place.

Yet in reality shares, Viatris should be trading for at least 12-14X earnings which would lead to a doubling of shares. On top of that we get a greater than 3% dividend yield as we wait for those gains to come in. So not so boring after all. 

What To Do Next?

Viatris (VTRS) is just one of 20 stellar stocks found in my Zen Investor portfolio.

And that portfolio is up +19.75% so far in 2026…yes even as the S&P 500 is under water. 

How is that possible? 

Investors are running away from overvalued junk and clamoring towards undervalued stocks with strong fundamentals. 

EXACTLY what the Zen Ratings model focuses on. 

EXACTLY what I have been doing as an investor over the last 40 years.  

To learn more about my unique investment process…and how to get access to my current top 20 stocks…just click the link below: 

Discover Zen Investor & Top 20 Stocks Now > 

Wishing you a world of investment success!

Steve Reitmeister…but everyone calls me Reity (pronounced “Righty”)

Editor of the Zen Investor

Want to get in touch? Email us at news@wallstreetzen.com.